David, Dolores D.
HRN: 21-50-11 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/29/2022
CEFTRIAXONE 1G (VIAL)
08/29/2022
09/05/2022
IV
2g
Q24
Infected Breast Ca
Waiting Final Action